Related Experiment Video

Updated: Jul 14, 2026

Exploring the Arginine Methylome by Nuclear Magnetic Resonance Spectroscopy
07:02

Exploring the Arginine Methylome by Nuclear Magnetic Resonance Spectroscopy

Published on: December 16, 2021

Hypomethylation of PRAME is responsible for its aberrant overexpression in human malignancies

Tino Schenk1, Sven Stengel, Stefanie Goellner

  • 1Department of Cell and Molecular Biology, Leibniz Institute for Natural Products Research and Infection Biology-Hans Knoell Institute, 07745 Jena, Germany.

Genes, Chromosomes & Cancer
|May 31, 2007
PubMed

Insights

Preferentially expressed antigen of melanoma (PRAME) is a key marker in various cancers. DNA methylation changes in PRAME

Area of Science:

  • Molecular oncology and epigenetics
  • Cancer biomarker research

Background:

  • Preferentially expressed antigen of melanoma (PRAME) is highly expressed in numerous human malignancies, including acute myeloid leukemia.
  • PRAME serves as a crucial diagnostic marker and a parameter for monitoring minimal residual disease in cancer patients.
  • The protein is implicated in tumorigenic processes, necessitating a deeper understanding of its regulation.

Purpose of the Study:

  • To investigate the transcriptional regulation of PRAME in detail.
  • To elucidate the role of DNA methylation in PRAME expression.
  • To identify specific regulatory regions involved in PRAME gene upregulation.

Main Methods:

  • Comprehensive DNA methylation analysis of the PRAME 5' regulatory region using genomic sequencing.
  • Correlation of DNA methylation patterns with PRAME expression levels in patient samples and cell lines.
  • DNA truncation and transfection experiments to assess the functional impact of methylation changes.

Main Results:

  • Significant correlation observed between DNA methylation patterns in specific regulatory regions and PRAME expression.
  • Alterations in DNA methylation within defined regions of the PRAME promoter are sufficient to induce gene upregulation.
  • Demonstrated that epigenetic modifications can drive PRAME expression in cells that typically do not express the gene.

Conclusions:

  • Epigenetic regulation, specifically DNA methylation, plays a critical role in controlling PRAME gene expression.
  • Changes in methylation patterns within the PRAME regulatory regions can lead to aberrant gene expression in cancer.
  • Findings provide insights into the molecular mechanisms underlying PRAME's role in tumorigenesis and its potential as a therapeutic target.

More Related Videos

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images09:42

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images

Published on: September 7, 2017

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...